- Origin: Missouri
- Grant awarded in: 2013
- Billiken Angels Network • BioGenerator • CIC@CET • Cultivation Capital • GatewayVMS • ITEN • Missouri Technology Corporation • Saint Louis University • St. Louis Arch Angels • Startup Connection • T-REX • University of Missouri System
President and Chief Operating Officer
Chief Technology Officer
Chairman/Chief Executive Officer
What is EternoGen?
EternoGen is a medical Bio-Tech company with a focus on designing and manufacturing a novel collagen scaffold for soft tissue therapeutic applications. EternoGen conducts research and development using expertise in clinical market evaluation, material science, and biological engineering to execute its clinical development model.
Luis Jimenez is the President and COO of EternoGen, a 2013 Arch Grants recipient.
Luis earned his degree in Chemical Engineering from University of Arkansas in 2009, and holds an MBA from University of Missouri-Columbia. Luis is an experienced business administrator and project manager with complementary skills in medical device engineering and product development, and brings experience working with Express Scripts and the Missouri Innovation Center to his position with EternoGen.
Sheila Grant is the Chief Technology Officer of EternoGen, a 2013 Arch Grants recipient.
Sheila earned her degree in Biomedical Engineering from Iowa State University, and holds a PhD in Materials Engineering from Iowa State University. Before joining EternoGen, Sheila worked with the University of Missouri and Michigan Technological University.
Anna Tenstam is the Chairman/Chief Executive Officer of EternoGen, a 2013 Arch Grants recipient.
Anna earned her degree in Social Sciences and Microbiology from Uppsala University in Sweden, and holds an MBA from Stockholm University. Anna brings experience as the Chairman and Co-Founder at E.stelle Medical and CCO at Timesulin Ltd to her position with EternoGen.